← Leaderboards
Imtiaz Ahmed Khan
George Washington University
$17,438,381
Attributed
$17,438,381
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,438,381 · 9
By mechanism
R01$16,125,562 · 6
R56$874,194 · 2
R21$438,625 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Exhibits”
- David R. Weir · University Of Michigan At Ann Arbor$259,685,758
- David W Simpson · University Of Southern California$143,628,960
- Abhik Das · Research Triangle Institute$100,700,289
- Omar N Ghattas · Carnegie Mellon University$94,000,000
- Kelly P Gaither · Purdue University$94,000,000
- Daniel Stanzione · Arizona State University$94,000,000
Research focus
ExhibitsImmunityInfectionLaboratoriesPathogenCd8b1 GeneMediatingResponseParasitesAcquired Immunodeficiency SyndromeImmunocompromised HostPlayLifeMemoryAntigensT-LymphocyteImmuneReportingToxoplasma GondiiCd4 Positive T LymphocytesCytokineToxoplasmosisMaintenanceHiv Infections
Grant awards (44)
CD4 dysfunction and cerebral toxoplasmosis$598,186
R01 · FY2025 · AI · contact PI
CD4 dysfunction and cerebral toxoplasmosis$598,186
R01 · FY2024 · AI · contact PI
CD4 dysfunction and cerebral toxoplasmosis$598,186
R01 · FY2023 · AI · contact PI
CD4 dysfunction and cerebral toxoplasmosis$547,146
R01 · FY2021 · AI · contact PI
CD4 dysfunction and cerebral toxoplasmosis$550,336
R01 · FY2020 · AI · contact PI
Long Term Immunity against Toxoplasmosis$396,250
R01 · FY2020 · AI · contact PI
Long Term Immunity against Toxoplasmosis$396,250
R01 · FY2019 · AI · contact PI
miR146a and CD4 dysfunction during chronic toxoplasmosis$239,250
R21 · FY2019 · AI · contact PI
Long Term Immunity against Toxoplasmosis$396,250
R01 · FY2018 · AI · contact PI
miR146a and CD4 dysfunction during chronic toxoplasmosis$199,375
R21 · FY2018 · AI · contact PI
Long Term Immunity against Toxoplasmosis$396,250
R01 · FY2017 · AI · contact PI
Long Term Immunity against Toxoplasmosis$396,250
R01 · FY2016 · AI · contact PI
CD8+ T cell effectors against microsporidia$399,225
R01 · FY2015 · AI · contact PI
CD8+ T Cell exhaustion during Toxoplasmosis$485,175
R56 · FY2014 · AI · contact PI
CD8+ T cell effectors against microsporidia$399,225
R01 · FY2014 · AI · contact PI
IL-21 dependent immunity to microsporidia$389,019
R56 · FY2013 · AI · contact PI
CD8+ T cell effectors against microsporidia$375,272
R01 · FY2013 · AI · contact PI
Long-term immunity against Toxoplasmosis$481,634
R01 · FY2012 · AI · contact PI
CD8+ T cell effectors against microsporidia$413,850
R01 · FY2012 · AI · contact PI
Long-term immunity against Toxoplasmosis$481,826
R01 · FY2011 · AI · contact PI
Long-term immunity against Toxoplasmosis$503,269
R01 · FY2010 · AI · contact PI
Dendritic Cell Response to Microsporidians$344,886
R01 · FY2010 · AI · contact PI
Long-term immunity against Toxoplasmosis$496,602
R01 · FY2009 · AI · contact PI
Dendritic Cell Response to Microsporidians$493,279
R01 · FY2009 · AI · contact PI
Dendritic Cell Response to Microsporidians$693,170
R01 · FY2008 · AI · contact PI
Long-term immunity against Toxoplasmosis$496,288
R01 · FY2008 · AI · contact PI
Encephalitozoan cuniculi-Host immunity and pathogenesis$479,362
R01 · FY2008 · AI · contact PI
Dendritic Cell Response to Microsporidians$537,420
R01 · FY2007 · AI · contact PI
Encephalitozoan cuniculi-Host immunity and pathogenesis$475,988
R01 · FY2007 · AI · contact PI
Dendritic Cell Response to Microsporidians$558,208
R01 · FY2006 · AI · contact PI
Encephalitozoan cuniculi-Host immunity and pathogenesis$445,305
R01 · FY2006 · AI · contact PI
IMMUNE ESCAPE MECHANISMS IN LEISHMANASIS$298,809
R01 · FY2006 · AI · contact PI
Long Term Immunity Against Toxoplasmosis$261,459
R01 · FY2006 · AI · contact PI
Encephalitozoan cuniculi-Host immunity and pathogenesis$452,598
R01 · FY2005 · AI
Long Term Immunity Against Toxoplasmosis$248,500
R01 · FY2005 · AI
Long Term Immunity Against Toxoplasmosis$248,500
R01 · FY2004 · AI
Encephalitozoan cuniculi-Host immunity and pathogenesis$229,903
R01 · FY2004 · AI
Long Term Immunity Against Toxoplasmosis$267,620
R01 · FY2003 · AI
LONG TERM IMMUNITY AGAINST TOXOPLASMOSIS$430,453
R01 · FY2001 · AI
ENCEPHALITOZOAN CUNICULI--HOST IMMUNITY AND PATHOGENESIS$221,460
R01 · FY2001 · AI
LONG TERM IMMUNITY AGAINST TOXOPLASMOSIS$153,590
R01 · FY2000 · AI
ENCEPHALITOZOAN CUNICULI--HOST IMMUNITY AND PATHOGENESIS$145,265
R01 · FY2000 · AI
LONG TERM IMMUNITY AGAINST TOXOPLASMOSIS$125,507
R01 · FY2000 · AI
ENCEPHALITOZOAN CUNICULI--HOST IMMUNITY AND PATHOGENESIS$93,799
R01 · FY2000 · AI